logo image
search icon
Nanomedicine Market

Nanomedicine Market Size, Share & Trends Analysis Report by Application (Therapeutics, In-Vitro Diagnostics, Drug Delivery, In-Vivo Imaging, And Implants), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type (Nanoparticles, Metal & Metal Oxide Nanoparticles, Liposomes, Polymers & Polymer-Drug Conjugates, Hydrogel Nanoparticles, Dendrimers, Inorganic Nanoparticles, Nanoshells, Nanotubes, And Nanodevices), Region And Segment Forecasts, 2023-2031

Report ID : 1889 | Published : 2024-05-17 | Pages: 180 | Format: PDF/EXCEL

The Global Nanomedicine Market Size is valued at 167.28 billion in 2022 and is predicted to reach 455.70 billion by the year 2031 at a 11.89% CAGR during the forecast period for 2023-2031.

Key Industry Insights & Findings from the Report:

  • Technological developments in areas like early illness diagnosis, chronic disease prevention, and preventative intervention are propelling the growth of the nanomedicine industry.
  • Rising sophisticated drug delivery methods are one of the key drivers driving the market's expansion and demand for nanomedicines. Consequently, this has cleared the path for the market's expansion.
  • North America dominated the market and accounted for a global revenue share in 2023.
  • The growth of the nanomedicine industry is being hindered by significant regulatory issues and the high expense of nanoparticle-assisted medicine in comparison to its conventional counterparts. However, in the near future, new challenges to the market's growth may arise from the hazards related to nanomedicine.

Nanomedicine Market

Nanomedicine is the use of nanotechnology in the realm of medicine. It entails using nanoscale materials and technology to diagnose, treat, and prevent diseases. Scientists and researchers may alter and control matter at the molecular and atomic levels by operating at the nanoscale, allowing for specific interactions with biological systems. Nanotechnology breakthroughs have broadened the potential for using nanoscale materials and devices in medicine.

The development of innovative nanomaterials, nanosensors, and nanodevices with enhanced characteristics and capabilities has accelerated the advancement of nanomedicine. Because of the increasing frequency of chronic diseases such as neurological disorders, cancer, and cardiovascular disease, there is a massive need for more effective and tailored treatment alternatives.

However, the epidemic has disrupted global supply chains, affecting the manufacture and distribution of nanomedicine products. Manufacturing delays, raw material shortages, and logistical issues have all hampered the availability and delivery of nanomedicine technologies such as nanomaterials, nanoparticles, and nanoscale devices.

Competitive Landscape:

Some of the Nanomedicine Market players are:

  • Abbott Laboratories
  • CombiMatrix Corporation
  • Celgene Corporation
  • Nanospectra Biosciences, Inc.
  • GE Healthcare
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Arrowhead Pharmaceuticals, Inc. 

Market Segmentation:

The Nanomedicine Market is segmented on the basis of application, indication scope, and molecule type. Application segment includes therapeutics, in-vitro diagnostics, drug delivery, In-vivo imaging, and implants. The indication scope segment includes clinical oncology, infectious diseases, clinical cardiology, orthopedics, and others. By molecule type, the market is segmented into nanoparticles, metal & metal oxide nanoparticles, liposomes, polymers & polymer-drug conjugates, hydrogel nanoparticles, dendrimers, inorganic nanoparticles, nanoshells, nanotubes, and nanodevices.

Based On Application, The Drug Delivery Segment Is Accounted As A Major Contributor In The Nanomedicine Market

The drug delivery category is expected to hold a major share in the global Nanomedicine Market in 2022 owing to the rising frequencies of various chronic and infectious diseases, including cancer and COVID-19, as well as increasing awareness of the potential uses for nanomedicines. Furthermore, an increase in research activities investigating the potential applications of nanomedicines in medication delivery is propelling the segment. In March 2023, for example, researchers at Memorial Sloan Kettering Cancer Centre and Mount Sinai Health System discovered a novel medication delivery technique for the targeted release of anti-cancer therapies for the treatment of pediatric brain tumors.

The Clinical Oncology Segment Witnessed Growth At A Rapid Rate

The clinical oncology segment is projected to grow at a rapid rate in the global Nanomedicine market. Due to the rising prevalence of cancer illnesses, a large number of cancer treatment products are now in clinical trials, as well as advancements in therapeutic particles and devices. Clinical oncology, which includes several active and passive cancer-targeting approaches within the nanomedicine business, is predicted to grow during the projection period.

In The Region, The North America Nanomedicine Market Holds A Significant Revenue Share

The North America Nanomedicine Market is expected to register the highest market share in terms of revenue in the near future. This growth is attributed to the presence of developing relationships between enterprises in this field and nanomedicine start-ups. Furthermore, the region benefits from government assistance as well as increased R&D investments. The country has a large number of manufacturing companies with active strategic ventures in the nanomedicine industry. The Asia Pacific market is anticipated to expand rapidly. This can be linked to increased public knowledge of nanomedicine and increased public participation in consensus conferences related to nanoscience and nanotechnology. 

Recent Developments:

  • In September 2022, NaNotics LLC, which is a biopharmaceutical business, stated that it will begin human trials as part of a research collaboration with Mass General Cancer Center, a branch of Massachusetts General Hospital (MGH) in Boston. Together, the two firms will create revolutionary subtractive nanoparticles known as NaNots that specifically target the soluble tumour necrosis factor receptors, which are immune inhibitors created by tumours.

Nanomedicine Market Report Scope:

Report Attribute

Specifications

Market Size Value In 2022

USD 167.28 Bn

Revenue Forecast In 2031

USD 455.70 Bn

Growth Rate CAGR

CAGR of 11.89 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

Type Of Technology, Product, Application, And End User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Abbott Laboratories; CombiMatrix Corporation; Celgene Corporation; Nanospectra Biosciences, Inc.; GE Healthcare; Johnson & Johnson Services, Inc.; Mallinckrodt Pharmaceuticals; Merck & Co., Inc.; Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.; Arrowhead Pharmaceuticals, Inc.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Nanomedicine Market Snapshot

Chapter 4. Global Nanomedicine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry

Chapter 5. Market Segmentation 1: By Application Estimates & Trend Analysis
5.1. By Application & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Application:

5.2.1. Therapeutics
5.2.2. in-vitro Diagnostics
5.2.3. Drug Delivery
5.2.4. In-vivo Imaging
5.2.5. Implants

Chapter 6. Market Segmentation 2: By Indication Estimates & Trend Analysis
6.1. By Indication & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Indication:

6.2.1. Clinical Oncology
6.2.2. Infectious diseases
6.2.3. Clinical Cardiology
6.2.4. Orthopedics
6.2.5. Others

Chapter 7. Market Segmentation 3: By Molecule Type Estimates & Trend Analysis
7.1. By Indication & Market Share, 2019-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Molecule Type:

7.2.1. Nanoparticles

7.2.1.1. Metal & Metal Oxide Nanoparticles
7.2.1.2. Liposomes
7.2.1.3. Polymers & polymer-drug conjugates
7.2.1.4. Hydrogel Nanoparticles
7.2.1.5. Dendrimers
7.2.1.6. Inorganic Nanoparticles

7.2.2. Nanoshells
7.2.3. Nanotubes
7.2.4. Nanodevices

Chapter 8. Nanomedicine Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Nanomedicine Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
8.1.2. North America Nanomedicine Market revenue (US$ Million) estimates and forecasts By Indication, 2023-2031
8.1.3. North America Nanomedicine Market revenue (US$ Million) estimates and forecasts By Molecule Type, 2023-2031
8.1.4. North America Nanomedicine Market revenue (US$ Million) estimates and forecasts by country, 2023-2031

8.1.4.1. U.S.
8.1.4.2. Canada

8.2. Europe

8.2.1. Europe Nanomedicine Market revenue (US$ Million) by By Application, 2023-2031
8.2.2. Europe Nanomedicine Market revenue (US$ Million) estimates and forecasts By Indication, 2023-2031
8.2.3. Europe Nanomedicine Market revenue (US$ Million) estimates and forecasts By Molecule Type, 2023-2031
8.2.4. Europe Nanomedicine Market revenue (US$ Million) by country, 2023-2031

8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Nanomedicine Market revenue (US$ Million) by By Application, 2023-2031
8.3.2. Asia Pacific Nanomedicine Market revenue (US$ Million) estimates and forecasts By Indication, 2023-2031
8.3.3. Asia Pacific Nanomedicine Market revenue (US$ Million) estimates and forecasts By Molecule Type, 2023-2031
8.3.4. Asia Pacific Nanomedicine Market revenue (US$ Million) by country, 2023-2031

8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific

8.4. Latin America

8.4.1. Latin America Nanomedicine Market revenue (US$ Million) by By Application, 2023-2031
8.4.2. Latin America Nanomedicine Market revenue (US$ Million) estimates and forecasts By Indication, 2023-2031
8.4.3. Latin America Nanomedicine Market revenue (US$ Million) estimates and forecasts By Molecule Type, 2023-2031
8.4.4. Latin America Nanomedicine Market revenue (US$ Million) by country, (US$ Million) 2023-2031
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America

8.5. Middle East & Africa

8.5.1. Middle East & Africa Nanomedicine Market revenue (US$ Million) by By Application, (US$ Million)
8.5.2. Middle East & Africa Nanomedicine Market revenue (US$ Million) estimates and forecasts By Indication, 2023-2031
8.5.3. Middle East & Africa Nanomedicine Market revenue (US$ Million) estimates and forecasts By Molecule Type, 2023-2031
8.5.4. Middle East & Africa Nanomedicine Market revenue (US$ Million) by country, (US$ Million) 2023-2031

8.5.4.1. South Africa
8.5.4.2. GCC Countries
8.5.4.3. Rest of MEA

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles


9.2.1. Abbott Laboratories
9.2.2. CombiMatrix Corporation
9.2.3. Celgene Corporation
9.2.4. Nanospectra Biosciences, Inc.
9.2.5. GE Healthcare
9.2.6. Johnson & Johnson Services, Inc.
9.2.7. Mallinckrodt Pharmaceuticals
9.2.8. Merck & Co., Inc.
9.2.9. Pfizer, Inc.
9.2.10. Teva Pharmaceutical Industries Ltd.
9.2.11. Arrowhead Pharmaceuticals, Inc.

Segmentation of Nanomedicine Market-

Nanomedicine Market By Application-

  • Therapeutics
  • In-vitro Diagnostics
  • Drug Delivery
  • In-vivo Imaging
  • Implants

Nanomedicine Market

Nanomedicine Market By Indication Scope -

  • Clinical Oncology
  • Infectious Diseases
  • Clinical Cardiology
  • Orthopedics
  • Others

Nanomedicine Market By Molecule Type-

  • Nanoparticles
    • Metal & Metal Oxide Nanoparticles
    • Liposomes
    • Polymers & Polymer Drug Conjugates
    • Hydrogel Nanoparticles
    • Dendrimers
    • Inorganic Nanoparticles
  • Nanoshells
  • Nanotubes
  • Nanodevices

Nanomedicine Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

 

 InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Nanomedicine Market?

Nanomedicine Market expected to grow at a 11.89% CAGR during the forecast period for 2023-2031

Abbott Laboratories; CombiMatrix Corporation; Celgene Corporation; Nanospectra Biosciences, Inc.; GE Healthcare; Johnson & Johnson Services, Inc.; Mal

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach